FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yolanda Bravo Vergel

Research Profile

Activities & Behaviors

Concepts & Ideas

Chemicals & Drugs

Disorders

Psoriatic Arthritis

Geographic Areas

Great Britain

Procedures

Co-author Network

Publications

TOP 3
Andrea Manca; Angela Meade; Mahesh Parmar; Christian Asseburg; Yolanda Bravo Vergel; Matt T Seymour; Richard Stephens; Mark J Sculpher
The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).
Laura Bojke; Karl Claxton; Yolanda Bravo Vergel; Mark J Sculpher; Stephen Palmer; Keith Abrams
Eliciting distributions to populate decision analytic models.
Yolanda Bravo Vergel; Mark J Sculpher
Quality-adjusted life years.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yolanda Bravo Vergel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Andrea Manca; Angela Meade; Mahesh Parmar; Christian Asseburg; Yolanda Bravo Vergel; Matt T Seymour; Richard Stephens; Mark J Sculpher
The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(1):22-31.
2010: Laura Bojke; Karl Claxton; Yolanda Bravo Vergel; Mark J Sculpher; Stephen Palmer; Keith Abrams
Eliciting distributions to populate decision analytic models.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010;13(5):557-64.
2008: Yolanda Bravo Vergel; Mark J Sculpher
Quality-adjusted life years.
Practical neurology 2008;8(3):175-82.
2007: Yolanda Bravo Vergel; N S Hawkins; Karl Claxton; Christian Asseburg; Stephen Palmer; Nerys F Woolacott; Ian Bruce; Mark J Sculpher
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.
Rheumatology (Oxford, England) 2007;46(11):1729-35.
2007: K Soares-Weiser; Yolanda Bravo Vergel; S Beynon; G Dunn; Marco Barbieri; S Duffy; J Geddes; Simon Gilbody; Stephen Palmer; Nerys F Woolacott
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Health technology assessment (Winchester, England) 2007;11(39):iii-iv, ix-206.
2007: Yolanda Bravo Vergel; Stephen Palmer; Christian Asseburg; Elisabeth Fenwick; Mark de Belder; Keith Abrams; Mark J Sculpher
Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis.
Heart (British Cardiac Society) 2007;93(10):1238-43.
2007: Christian Asseburg; Yolanda Bravo Vergel; Stephen Palmer; Elisabeth Fenwick; Mark de Belder; Keith Abrams; Mark J Sculpher
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis.
Heart (British Cardiac Society) 2007;93(10):1244-50.
2006: Nerys F Woolacott; Neil Hawkins; Anne R Mason; Anita Kainth; Z C S Khadjesari; Yolanda Bravo Vergel; Kate Misso; Kate Light; R Chalmers; Mark J Sculpher; Rob Riemsma
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Health technology assessment (Winchester, England) 2006;10(46):1-233, i-iv.
2006: Nerys F Woolacott; Yolanda Bravo Vergel; Neil Hawkins; Anita Kainth; Z C S Khadjesari; Kate Misso; Kate Light; Christian Asseburg; Stephen Palmer; Karl Claxton; I Bruce; Mark J Sculpher; Rob Riemsma
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2006;10(31):iii-iv, xiii-xvi, 1-239.
2006: Yolanda Bravo Vergel; Mark J Sculpher
Making decisions under uncertainty--the role of probabilistic decision modelling.
Family practice 2006;23(4):391-2.
2006: Yolanda Bravo Vergel; Brian Ferguson
Difficult commissioning choices: lessons from English primary care trusts.
Journal of health services research & policy 2006;11(3):150-4.
2006: Yolanda Bravo Vergel; James Chilcott; Eva Kaltenthaler; Stephen Walters; Anthony Blakeborough; Steven Thomas
Economic evaluation of MR cholangiopancreatography compared to diagnostic ERCP for the investigation of biliary tree obstruction.
International journal of surgery (London, England) 2006;4(1):12-9.
2006: Eva Kaltenthaler; Stephen J Walters; James Chilcott; Anthony Blakeborough; Yolanda Bravo Vergel; Steven Thomas
MRCP compared to diagnostic ERCP for diagnosis when biliary obstruction is suspected: a systematic review.
BMC medical imaging 2006;6():9.
2004: Eva Kaltenthaler; Yolanda Bravo Vergel; James Chilcott; Steven Thomas; T Blakeborough; Stephen J Walters; H Bouchier
A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography.
Health technology assessment (Winchester, England) 2004;8(10):iii, 1-89.